Michael Corbel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michael Corbel has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Alex Douglas-Bardsley
National Institute for Biological Standards and Control (NIBSC); South Mimms, Potters Bar, Hertfordshire UK
2 shared publications- Catpagavalli Asokanathan
Division of Bacteriology, National Institute of Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Hertfordshire EN6 3QG, UK
2 shared publications Barbara Bolgiano
National Institute for Biological Standards and Control (NIBSC); South Mimms, Potters Bar, Hertfordshire UK
1 shared publicationCatpagavalli Asokanathan
National Institute for Biological Standards and Control (NIBSC); South Mimms, Potters Bar, Hertfordshire UK
1 shared publicationDorothy Xing
A National Institute for Biological Standards and Control (NIBSC); South Mimms, Potters Bar, Hertfordshire UK
1 shared publication- Dorothy Xing
Division of Bacteriology, National Institute of Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Hertfordshire EN6 3QG, UK
1 shared publication
Latest Publications
- 30 April 2014
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 10 (7) , 2066-2073
Relationship of immunogenicity to protective potency in acellular pertussis vaccines
Comparison of the immunogenicity response and resistance to challenge in the modified intracerebral challenge assay induced by various acellular pertussis vaccines showed that these were not closely linked. The immunogenicity assay was effective for confirming the presence of specific antigenic components and was invaluable for detecting minor components present in co-purified vaccines. However, the magnitude of antibody responses was not consistently related to antigen concentration nor did it correlate with protection in the modified intracerebral challenge assay. The immunogenicity assay detected degradation of pertussis toxin and pertactin components but not of filamentous haemagglutinin or fimbriae 2 and 3 in denatured acellular pertussis vaccines. The modified intracerebral challenge assay was effective in detecting antigen degradation in all types of acellular pertussis vaccines including those of European/North American origin but was dominated by the response to pertussis toxin. Aerosol challenge...
- 30 April 2014
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 10 (7) , 2066-2073
Relationship of immunogenicity to protective potency in acellular pertussis vaccines
Comparison of the immunogenicity response and resistance to challenge in the modified intracerebral challenge assay induced by various acellular pertussis vaccines showed that these were not closely linked. The immunogenicity assay was effective for confirming the presence of specific antigenic components and was invaluable for detecting minor components present in co-purified vaccines. However, the magnitude of antibody responses was not consistently related to antigen concentration nor did it correlate with protection in the modified intracerebral challenge assay. The immunogenicity assay detected degradation of pertussis toxin and pertactin components but not of filamentous haemagglutinin or fimbriae 2 and 3 in denatured acellular pertussis vaccines. The modified intracerebral challenge assay was effective in detecting antigen degradation in all types of acellular pertussis vaccines including those of European/North American origin but was dominated by the response to pertussis toxin. Aerosol challenge...
- 1 March 2014
- Published by Elsevier in Biologicals
- Vol. 42 (2) , 101-108
An international collaborative study of the effect of active pertussis toxin on the modified Kendrick test for acellular pertussis vaccines
- 1 March 2014
- Published by Elsevier in Biologicals
- Vol. 42 (2) , 101-108
An international collaborative study of the effect of active pertussis toxin on the modified Kendrick test for acellular pertussis vaccines
- Open Access
- 1 February 2013
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 9 (2) , 325-331
A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response againstBordetella pertussis
We investigated the adjuvant effect of CpG ODN alone or in combination with aluminum hydroxide on the immune response to the three main antigens presented in current acellular pertussis vaccines: pertussis toxoid, filamentous haemagglutinin and pertactin. The development of protection in mice was investigated for the intra-peritoneal and intra-nasal immunisation routes. The results showed that CpG ODN alone, or in combination with aluminum hydroxide, gave enhancement in anti-pertussis toxin, anti- filamentous haemagglutinin and especially anti-pertactin titers after mucosal immunisation. Higher macrophage NO levels indicating activation were found when the antigens were co-formulated with CpG ODN. Vaccines containing CpG ODN gave enhanced humoral and CMI responses with a shift toward Th-1 and increased protection against challenge infection with B.pertussis in mice.
- 1 February 2013
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 9 (2) , 325-331
Open AccessA CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response againstBordetella pertussis
We investigated the adjuvant effect of CpG ODN alone or in combination with aluminum hydroxide on the immune response to the three main antigens presented in current acellular pertussis vaccines: pertussis toxoid, filamentous haemagglutinin and pertactin. The development of protection in mice was investigated for the intra-peritoneal and intra-nasal immunisation routes. The results showed that CpG ODN alone, or in combination with aluminum hydroxide, gave enhancement in anti-pertussis toxin, anti- filamentous haemagglutinin and especially anti-pertactin titers after mucosal immunisation. Higher macrophage NO levels indicating activation were found when the antigens were co-formulated with CpG ODN. Vaccines containing CpG ODN gave enhanced humoral and CMI responses with a shift toward Th-1 and increased protection against challenge infection with B.pertussis in mice.